126 related articles for article (PubMed ID: 12805720)
1. Premalignant lesions in the kidney.
Kirkali Z; Yorukoglu K
ScientificWorldJournal; 2001 Dec; 1():855-67. PubMed ID: 12805720
[TBL] [Abstract][Full Text] [Related]
2. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
3. Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma.
Yörükoğlu K; Aktas S; Mungan MU; Kirkali Z
Urology; 1999 Apr; 53(4):684-9. PubMed ID: 10197841
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alterations during renal carcinogenesis.
Arai E; Kanai Y
Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: evidence of a precursor lesion.
Lai R; el Dabbagh L; Mourad WA
Mod Pathol; 1996 Jun; 9(6):690-5. PubMed ID: 8782209
[TBL] [Abstract][Full Text] [Related]
6. Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma.
Pehlivan S; Koyuncuoglu M; Pehlivan M; Izzetoglu S; Mater Y; Cabuk M; Kirkali Z
World J Urol; 2004 Jun; 22(2):120-3. PubMed ID: 14689223
[TBL] [Abstract][Full Text] [Related]
7. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic tubular epithelium in "normal" kidney associated with renal cell carcinoma.
Mourad WA; Nestok BR; Saleh GY; Solez K; Power RF; Jewell LD
Am J Surg Pathol; 1994 Nov; 18(11):1117-24. PubMed ID: 7943532
[TBL] [Abstract][Full Text] [Related]
9. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.
Dias F; Teixeira AL; Santos JI; Gomes M; Nogueira A; Assis J; Medeiros R
Pharmacogenomics; 2013 Nov; 14(14):1793-803. PubMed ID: 24192126
[TBL] [Abstract][Full Text] [Related]
11. Requirement for the von Hippel-Lindau tumor suppressor gene for functional epidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma.
Perera AD; Kleymenova EV; Walker CL
Clin Cancer Res; 2000 Apr; 6(4):1518-23. PubMed ID: 10778984
[TBL] [Abstract][Full Text] [Related]
12. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
13. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.
Minner S; Rump D; Tennstedt P; Simon R; Burandt E; Terracciano L; Moch H; Wilczak W; Bokemeyer C; Fisch M; Sauter G; Eichelberg C
Cancer; 2012 Mar; 118(5):1268-75. PubMed ID: 22161775
[TBL] [Abstract][Full Text] [Related]
16. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
17. Update on the epidemiology and biology of renal cortical neoplasms.
Collins S; McKiernan J; Landman J
J Endourol; 2006 Dec; 20(12):975-85. PubMed ID: 17206887
[TBL] [Abstract][Full Text] [Related]
18. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
19. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer.
Smith K; Gunaratnam L; Morley M; Franovic A; Mekhail K; Lee S
Cancer Res; 2005 Jun; 65(12):5221-30. PubMed ID: 15958567
[TBL] [Abstract][Full Text] [Related]
20. Pathology of preneoplastic and neoplastic renal tubular lesions induced in F-344 rats by sodium barbital, a nongenotoxic renal carcinogen and nephrotoxin.
Kurata Y; Diwan BA; Uno H; Rice JM; Ward JM
Toxicol Pathol; 1993; 21(1):35-45. PubMed ID: 8378705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
